https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-09-24 / Int J Hyperthermia 2012;28(8):707-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-09-24 / Int J Hyperthermia 2012;28(8):707-142012-09-24 00:00:002019-02-15 08:39:16Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-09-11 / Int. J. Oncol. 2012 Nov;41(5):1601-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-09-11 / Int. J. Oncol. 2012 Nov;41(5):1601-92012-09-11 00:00:002012-09-11 00:00:00Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-09-10 / JOP 2012 Sep;13(5):502-13
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-09-10 / JOP 2012 Sep;13(5):502-132012-09-10 00:00:002012-09-10 00:00:00Two avirulent, lentogenic strains of Newcastle disease virus are cytotoxic for some human pancreatic tumor lines in vitro
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2012-09-01 / Cancer Immunol Immunother 2012 Sep;61(9):1415-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2012-09-01 / Cancer Immunol Immunother 2012 Sep;61(9):1415-242012-09-01 00:00:002023-03-07 13:03:07Autologous dendritic cell vaccine for estrogen receptor (ER)/progestin receptor (PR) double-negative breast cancer
